Vimarsana
Biggest News Aggregation in the World

Splanchnic Ablation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Splanchnic Ablation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Splanchnic Ablation Today - Breaking & Trending Today

Late-Breaking Data Confirms Safety of Axon Therapies' Innovative Heart Failure Procedure and Identifies Patients Most Likely to Benefit from SAVM Therapy - Vimarsana News

Late-Breaking Data Confirms Safety of Axon Therapies' Innovative Heart Failure Procedure and Identifies Patients Most Likely to Benefit from SAVM Therapy

Published: October 10, 2023

REBALANCE-HF early feasibility trial met objective of identifying responder group with demonstrated benefits in heart function, hemodynamics, and physical activity at 6 months

Source: dicardiology.com
Related Topics:
United StatesSanjiv ShahBluhm Cardiovascular InstituteDuke UniversityHeart Failure Society Of AmericaFeinberg School Of MedicineNorthwestern UniversityAxon TherapiesSplanchnic AblationVolume ManagementMarat FudimAdvanced Heart Failure SpecialistMedical CenterLate Breaking Clinical TrialsHeart Failure SocietyAnnual Scientific MeetingPrincipal InvestigatorFeinberg SchoolKansas City Cardiomyopathy QuestionnaireChad HoskinsChief Executive Officer
Axon Therapies Announces Positive Early Clinical Data from REBALANCE-HF Randomized Clinical Trial - Vimarsana News

Axon Therapies Announces Positive Early Clinical Data from REBALANCE-HF Randomized Clinical Trial

Published: May 26, 2022

Late-breaking results presented at the European Society of Cardiology's Heart Failure Association annual conference and simultaneously published online in the European Journal of Heart Failure

Source: dicardiology.com
Related Topics:
United StatesNorthwestern UniversitySanjiv ShahYork Heart AssociationNational Principal InvestigatorFeinberg School Of MedicineResearch For The Bluhm Cardiovascular InstituteDuke UniversityEuropean Society Of Cardiology Heart Failure AssociationAxon TherapiesSplanchnic AblationVolume ManagementEuropean SocietyHeart Failure AssociationEuropean JournalMarat FudimAdvanced Heart Failure SpecialistAxon AblationNew York Heart AssociationBluhm Cardiovascular InstituteFeinberg SchoolChad Hoskins
Axon Therapies Announces Positive Early Clinical Data from REBALANCE-HF Randomized Clinical Trial - Vimarsana News

Axon Therapies Announces Positive Early Clinical Data from REBALANCE-HF Randomized Clinical Trial

Published: May 23, 2022

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Related Topics:
York Heart AssociationAxon Therapies IncEuropean Society Of Cardiology Heart Failure AssociationEuropean SocietyHeart Failure AssociationEuropean JournalSplanchnic AblationVolume ManagementMarat FudimAdvanced Heart Failure SpecialistDuke University MedicalAxon AblationNew York Heart AssociationAxon TherapiesAxon Ablation SystemDeerfield ManagementAction Potential Venture CapitalPr NewswireHeart FailureClinical Trials